Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Dapagliflozin 10mg Tab Sponsor:   Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials

Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
Condition:   Inflammatory Bowel Diseases Interventions:   Drug: Mesalamine;   Drug: Fenofibrate Sponsors:   Tanta University;   Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;   Fedaa Abd El-monem Kamal El-deen Kotkata Faculty of Pharmacy, Tanta University;   Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials